The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...
Find out about TECregen's, a Basel-based company developing novel biologics designed to rejuvenate the thymus, “thymopoietics ...
As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback